Millennium Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,959,870
| Closed | -$156M | – | 6865 |
|
|
2023
Q2 | $156M | Buy |
3,959,870
+2,719,573
| +219% | +$96M | 0.08% | 187 |
|
|
2023
Q1 | $30.2M | Sell |
1,240,297
-931,236
| -43% | -$20.4M | 0.02% | 1026 |
|
|
2022
Q4 | $46.5M | Buy |
2,171,533
+846,603
| +64% | +$18.1M | 0.03% | 798 |
|
|
2022
Q3 | $23.8M | Sell |
1,324,930
-284,565
| -18% | -$3.74M | 0.01% | 1190 |
|
|
2022
Q2 | $15.5M | Buy |
1,609,495
+346,536
| +27% | +$4.35M | 0.01% | 1554 |
|
|
2022
Q1 | $21.3M | Sell |
1,262,959
-208,989
| -14% | -$3.09M | 0.01% | 1331 |
|
|
2021
Q4 | $24.6M | Buy |
1,471,948
+731,394
| +99% | +$12M | 0.01% | 1262 |
|
|
2021
Q3 | $12M | Sell |
740,554
-411,396
| -36% | -$4.48M | 0.01% | 1829 |
|
|
2021
Q2 | $7.27M | Buy |
1,151,950
+325,936
| +39% | +$2.1M | ﹤0.01% | 2288 |
|
|
2021
Q1 | $5.11M | Buy |
826,014
+21,387
| +3% | +$130K | ﹤0.01% | 2546 |
|
|
2020
Q4 | $5.56M | Sell |
804,627
-132,714
| -14% | -$849K | ﹤0.01% | 2343 |
|
|
2020
Q3 | $5.29K | Buy |
937,341
+14,377
| +2% | +$68.6K | 0.01% | 1786 |
|
|
2020
Q2 | $4.71M | Sell |
922,964
-425,536
| -32% | -$1.77M | 0.01% | 1820 |
|
|
2020
Q1 | $4.64M | Buy |
1,348,500
+474,633
| +54% | +$2.77M | 0.01% | 1381 |
|
|
2019
Q4 | $7.5M | Buy |
+873,867
| New | +$3.12M | 0.01% | 1614 |
|
|
2019
Q3 | – | Sell |
-28,207
| Closed | -$37K | – | 4665 |
|
|
2019
Q2 | $37K | Sell |
28,207
-25,559
| -48% | -$35.1K | ﹤0.01% | 3961 |
|
|
2019
Q1 | $76K | Buy |
+53,766
| New | +$75.2K | ﹤0.01% | 3878 |
|
|
2018
Q4 | – | Sell |
-48,902
| Closed | -$115K | – | 4312 |
|
|
2018
Q3 | $115K | Sell |
48,902
-133,645
| -73% | -$333K | ﹤0.01% | 3722 |
|
|
2018
Q2 | $498K | Sell |
182,547
-155,965
| -46% | -$430K | ﹤0.01% | 3169 |
|
|
2018
Q1 | $928K | Sell |
338,512
-669,378
| -66% | -$1.94M | ﹤0.01% | 2726 |
|
|
2017
Q4 | $3.15M | Buy |
1,007,890
+339,656
| +51% | +$955K | ﹤0.01% | 1999 |
|
|
2017
Q3 | $1.88M | Sell |
668,234
-98,144
| -13% | -$265K | ﹤0.01% | 2199 |
|
|
2017
Q2 | $1.96M | Sell |
766,378
-113,649
| -13% | -$310K | ﹤0.01% | 2082 |
|
|
2017
Q1 | $3.22M | Sell |
880,027
-363,959
| -29% | -$1.54M | 0.01% | 1724 |
|
|
2016
Q4 | $6.01M | Buy |
1,243,986
+879,033
| +241% | +$26.1M | 0.01% | 1209 |
|
|
2016
Q3 | $16.8M | Sell |
364,953
-439,341
| -55% | -$24.8M | 0.03% | 661 |
|
|
2016
Q2 | $41M | Buy |
804,294
+558,065
| +227% | +$27.7M | 0.09% | 262 |
|
|
2016
Q1 | $10.4M | Sell |
246,229
-834,396
| -77% | -$42.5M | 0.03% | 810 |
|
|
2015
Q4 | $84.9M | Buy |
1,080,625
+1,047,947
| +3,207% | +$60.6M | 0.18% | 93 |
|
|
2015
Q3 | $1.32M | Buy |
32,678
+1,209
| +4% | +$64K | ﹤0.01% | 2138 |
|
|
2015
Q2 | $1.64M | Sell |
31,469
-51,169
| -62% | -$2.55M | ﹤0.01% | 2031 |
|
|
2015
Q1 | $3.85M | Sell |
82,638
-25,025
| -23% | -$1.3M | 0.01% | 1560 |
|
|
2014
Q4 | $4.83M | Buy |
107,663
+99,988
| +1,303% | +$4.2M | 0.01% | 1415 |
|
|
2014
Q3 | $299K | Sell |
7,675
-36,683
| -83% | -$1.44M | ﹤0.01% | 3094 |
|
|
2014
Q2 | $1.88M | Buy |
+44,358
| New | +$1.63M | 0.01% | 1823 |
|
|
2014
Q1 | – | Sell |
-75,000
| Closed | -$2.53M | – | 3986 |
|
|
2013
Q4 | $2.43M | Buy |
+75,000
| New | +$2.23M | 0.01% | 1686 |
|
Millennium Management's ISEE Position: Q3 2023 in Review
Millennium Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 3,959,870 shares — an estimated $156M sold.
Millennium Management first reported a position in ISEE in Q4 2013 and held it in 36 quarters. The position peaked at $156M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Millennium Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Millennium Management sold 3,959,870 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $156M.
- Millennium Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 36 quarters.
- Millennium Management's IVERIC bio, Inc. Common Stock position peaked at $156M in Q2 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.